Indiba Active CT9 Products

“INDIBA” is a great addition to our physical therapy approach. We treat a wide range of clients with MSK, from elite athletes to geriatric patients. The results it provides are far superior to any other electrotherapy device I have used in my career. Customers enjoy the treatment and the results are visible immediately.
We have been able to accelerate rehabilitation and return to action in many cases of acute injury by introducing INDIBA® to athletes. INDIBA ® has allowed us to improve the outcome of our clients’ recovery from chronic diseases, when compared to other devices’ treatment regimens. Our clinic absolutely loves it”
Saira Rehman
Physiotherapist

Exclusive 448 kHz radio frequency technology

Over 35 years of experience

Over 25,000 devices globally

History

In 1983, Mr. José Calbet began to research the therapeutic applications of radiofrequency electromagnetic currents and produced our first device, now called INDIBA®. Earlier we called it TEC or TECAR. Today we are going to introduce you to this technology, referred to by the scientific community as CRET or CRMRF (capacitive resistive radio frequency).

Since that first device, we have continued to develop our technology
I rotated around 0.5 MHz and identified a special frequency at 448 kHz.

Gold Medal

“International Exhibition on
invention”
Geneva

Silver Medal

Invention Exhibition
Eureka”
Brussels

Gold Medal

“International Exhibition
Inventallia”
Madrid

Treatment

The INDIBA® treatment stimulates tissue regeneration, which can be combined with manual therapy and other techniques to produce excellent results.
Using the precise frequency of 448 kHz achieve thermal and non-thermal effects:
• Pain relief
• Increase the volume and intensity of blood inside the body
• Increased supply of oxygen and nutrients
• Increase tissue temperature
• Increase metabolism
• Control inflammation
• Normalize cells, restore function of cell membranes
• Achieve ionic balance
• Stimulate cell proliferation

Fat – Stem cell proliferation derived (in vitro)

Treatment with 448 kHz electrical stimulation increased cartilage-specific type II collagen by 51% and glycosaminoglycan by 20% for the placebo group.

Improvement of pain and function in osteoarthritis RCT

4 weeks of INDIBA® treatment with exercise and counseling (control and placebo groups) with 3 months of follow-up

The INDIBA® treated group experienced a 66% reduction in pain compared with baseline, and over the next 3 months, pain was reduced by 45%. Control group increased by 8% (Quality of functional life as measured by WOMAC); 45% point reduction after 4 weeks and 38% after 3 months.

blood flow response to INDIBA® applications

Skin feedback from 17 participants showed a significant change in the INDIBA® treated group compared with the placebo and control groups.

ACTIV 7

Energy
Cap 250 VA+ Res 65W
Size
37 X 40 X 17 cm
Weight
10k

ACTIV 8

Energy
Cap 350 VA+ Res 100W
Size
37 X 40 X 17 cm
Weight
10 kg

CT8

Energy
Cap 350 VA+ Res 100W
Size
40 X 53 X 15 cm
Weight
8.4 kg

CT9

Energy
Cap 450 VA + Res 200 W
Size
40 X 53 X 15 cm
Weight
8.6 kg

Specifications